Item 2 Issuer Principal Place of Business and Contact Information
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064-6400
Phone Number:
subscription required
Item 3. Related Persons
Name
RICHARD A. GONZALEZ
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
ROBERT J. ALPERN
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
ROXANNE S. AUSTIN
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
WILLIAM H.L. BURNSIDE
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
EDWARD M. LIDDY
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
BRETT J. HART
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
EDWARD J. RAPP
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
GLENN F. TILTON
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
FREDERICK H. WADDELL
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
LAURA J. SCHUMACHER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
WILLIAM J. CHASE
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
MICHAEL E. SEVERINO
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
CARLOS ALBAN
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
HENRY GOSEBRUCH
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
TIMOTHY J. RICHMOND
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
AZITA SALEKI-GERHARDT
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
THOMAS A. HURWICH
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
OVER $100,000,000
Item 6. Federal Exemptions and Exclusions Claimed
06B
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
04/25/2016
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Equity
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
Yes
Clarification of Response
THIS OFFERING IS MADE IN CONNECTION WITH THE ACQUSITION OF STEMCENTRX, INC.
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
3800000000
Total Amount Sold
3800000000
Total Remaining to be Sold
0
Clarification of Response
ABBVIE INC. WILL ISSUE 62.5 MILLION SHARES OF ABBVIE COMMON STOCK IN THE TRANSACTION. THE TOTAL OFFERING AMOUNT IS CALCULATED BASED ON A FIXED VALUE OF $60.664 PER SHARE.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
39
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Notice has been signed on behalf by the undersigned duly authorized person